Dagher Ibrahim B. 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Jul 24, 2024
Insider Transaction Report
Form 4
Dagher Ibrahim B.
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-07-19$0.35/sh−63,000$22,069→ 0 total
Holdings
- 160,000(indirect: By IRA)
Common Stock
- 30,000(indirect: See Note)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.3455 to $0.366, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]Represents shares held in a custodial account under the Uniform Transfers to Minors Act for the benefit of the Reporting Person's child. The Reporting Person is the custodian of such account. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.